Research from Denmark suggests initiating statin therapy soon after a type 2 diabetes diagnosis could lower the risk of developing dementia later in life, highlighting the potential added benefits of early vascular protection.
New Danish research suggests that starting statin treatment soon after a type 2 diabetes diagnosis may be linked to a lower risk of dementia later in life, adding to evidence that protecting blood vessels may also help protect the brain. The study, presented at ESC Congress 2026 and published in The Lancet Regional Health – Europe, followed more than 132,000 people with type 2 diabetes and found the strongest association when statins were begun within the first year of diagnosis.
Statins are widely prescribed to lower LDL cholesterol, the particle often called “bad” cholesterol because high levels can contribute to fatty build-up in arteries and raise the risk of heart attack and stroke. That matters in type 2 diabetes, where the risk of cardiovascular disease is already elevated. Researchers have increasingly looked at whether the same measures that reduce vascular damage may also lower the odds of cognitive decline.
According to the Danish team, which used national health registers, the analysis included 132,585 people diagnosed with type 2 diabetes between 2006 and 2019 who had not previously used statins. Participants were followed through the end of 2021, with a median follow-up of 7.1 years. During that time, 2.7% received a dementia diagnosis.
People who started statins within a year of diabetes diagnosis had a 15% lower relative risk of dementia over 10 years than those who did not begin treatment in the first five years. Those who started between one and five years after diagnosis had a 10% lower relative risk. The pattern was similar in women and men, suggesting the timing of treatment may matter.
The findings do not prove that statins prevent dementia. Because the research was observational, it can show an association but cannot rule out all differences between people who started treatment early and those who did not. Even so, the results add weight to the idea that earlier control of cholesterol may have benefits beyond the heart, especially for people with diabetes and high LDL cholesterol. Doctors would still need to weigh cardiovascular risk, age, other conditions and possible side effects before deciding on treatment.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
